DK3012633T3 - Immunkromatografianordning til detektering af RSV - Google Patents
Immunkromatografianordning til detektering af RSV Download PDFInfo
- Publication number
- DK3012633T3 DK3012633T3 DK14814429.8T DK14814429T DK3012633T3 DK 3012633 T3 DK3012633 T3 DK 3012633T3 DK 14814429 T DK14814429 T DK 14814429T DK 3012633 T3 DK3012633 T3 DK 3012633T3
- Authority
- DK
- Denmark
- Prior art keywords
- rsv
- protein
- antibody
- sample
- immuno
- Prior art date
Links
- 238000003317 immunochromatography Methods 0.000 title claims description 65
- 238000001514 detection method Methods 0.000 title description 15
- 241000725643 Respiratory syncytial virus Species 0.000 claims description 160
- 108010068327 4-hydroxyphenylpyruvate dioxygenase Proteins 0.000 claims description 90
- 238000002372 labelling Methods 0.000 claims description 82
- 101710141454 Nucleoprotein Proteins 0.000 claims description 64
- 239000003153 chemical reaction reagent Substances 0.000 claims description 60
- 239000012501 chromatography medium Substances 0.000 claims description 51
- 238000012360 testing method Methods 0.000 claims description 35
- 239000003085 diluting agent Substances 0.000 claims description 34
- 239000007788 liquid Substances 0.000 claims description 31
- 238000000034 method Methods 0.000 claims description 31
- 238000010521 absorption reaction Methods 0.000 claims description 17
- 238000004587 chromatography analysis Methods 0.000 claims description 6
- 238000007865 diluting Methods 0.000 claims description 5
- 238000003556 assay Methods 0.000 claims 2
- 238000010186 staining Methods 0.000 claims 1
- 239000000523 sample Substances 0.000 description 159
- 235000018102 proteins Nutrition 0.000 description 58
- 102000004169 proteins and genes Human genes 0.000 description 58
- 108090000623 proteins and genes Proteins 0.000 description 58
- 239000000243 solution Substances 0.000 description 34
- 239000000427 antigen Substances 0.000 description 30
- 102000036639 antigens Human genes 0.000 description 30
- 108091007433 antigens Proteins 0.000 description 30
- 241000700605 Viruses Species 0.000 description 24
- 206010061603 Respiratory syncytial virus infection Diseases 0.000 description 22
- 238000002360 preparation method Methods 0.000 description 16
- 239000002245 particle Substances 0.000 description 13
- 210000004027 cell Anatomy 0.000 description 12
- 239000000126 substance Substances 0.000 description 11
- 125000000391 vinyl group Chemical group [H]C([*])=C([H])[H] 0.000 description 11
- 229920002554 vinyl polymer Polymers 0.000 description 11
- 210000004408 hybridoma Anatomy 0.000 description 10
- 239000000203 mixture Substances 0.000 description 9
- 229920003169 water-soluble polymer Polymers 0.000 description 9
- 230000001965 increasing effect Effects 0.000 description 8
- 238000005259 measurement Methods 0.000 description 8
- 108090000765 processed proteins & peptides Proteins 0.000 description 8
- 208000024891 symptom Diseases 0.000 description 8
- 241001465754 Metazoa Species 0.000 description 7
- 125000003275 alpha amino acid group Chemical group 0.000 description 7
- 239000006172 buffering agent Substances 0.000 description 7
- 239000000463 material Substances 0.000 description 7
- 102000004196 processed proteins & peptides Human genes 0.000 description 7
- 238000010998 test method Methods 0.000 description 7
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 6
- 239000003365 glass fiber Substances 0.000 description 6
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 6
- 229920001184 polypeptide Polymers 0.000 description 6
- 108091003079 Bovine Serum Albumin Proteins 0.000 description 5
- 229940098773 bovine serum albumin Drugs 0.000 description 5
- 238000006243 chemical reaction Methods 0.000 description 5
- 230000000052 comparative effect Effects 0.000 description 5
- 230000002163 immunogen Effects 0.000 description 5
- 239000002736 nonionic surfactant Substances 0.000 description 5
- -1 polyoxyethylene Polymers 0.000 description 5
- 150000003839 salts Chemical class 0.000 description 5
- 239000004094 surface-active agent Substances 0.000 description 5
- 206010003445 Ascites Diseases 0.000 description 4
- 102000004190 Enzymes Human genes 0.000 description 4
- 108090000790 Enzymes Proteins 0.000 description 4
- 206010039101 Rhinorrhoea Diseases 0.000 description 4
- 238000003149 assay kit Methods 0.000 description 4
- 238000004040 coloring Methods 0.000 description 4
- 229940088598 enzyme Drugs 0.000 description 4
- 208000015181 infectious disease Diseases 0.000 description 4
- 230000001524 infective effect Effects 0.000 description 4
- 239000012528 membrane Substances 0.000 description 4
- 238000002156 mixing Methods 0.000 description 4
- 208000010753 nasal discharge Diseases 0.000 description 4
- 230000035945 sensitivity Effects 0.000 description 4
- 238000001179 sorption measurement Methods 0.000 description 4
- WHNPOQXWAMXPTA-UHFFFAOYSA-N 3-methylbut-2-enamide Chemical compound CC(C)=CC(N)=O WHNPOQXWAMXPTA-UHFFFAOYSA-N 0.000 description 3
- IMROMDMJAWUWLK-UHFFFAOYSA-N Ethenol Chemical compound OC=C IMROMDMJAWUWLK-UHFFFAOYSA-N 0.000 description 3
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 3
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 3
- 239000007983 Tris buffer Substances 0.000 description 3
- XTXRWKRVRITETP-UHFFFAOYSA-N Vinyl acetate Chemical compound CC(=O)OC=C XTXRWKRVRITETP-UHFFFAOYSA-N 0.000 description 3
- 229910052783 alkali metal Inorganic materials 0.000 description 3
- 150000001340 alkali metals Chemical class 0.000 description 3
- 230000000903 blocking effect Effects 0.000 description 3
- 210000004369 blood Anatomy 0.000 description 3
- 239000008280 blood Substances 0.000 description 3
- 210000000170 cell membrane Anatomy 0.000 description 3
- 239000001913 cellulose Substances 0.000 description 3
- 229920002678 cellulose Polymers 0.000 description 3
- 229920001577 copolymer Polymers 0.000 description 3
- 238000007334 copolymerization reaction Methods 0.000 description 3
- 239000012228 culture supernatant Substances 0.000 description 3
- 238000001035 drying Methods 0.000 description 3
- 239000010931 gold Substances 0.000 description 3
- 229910052737 gold Inorganic materials 0.000 description 3
- 210000004379 membrane Anatomy 0.000 description 3
- 239000002923 metal particle Substances 0.000 description 3
- 125000004430 oxygen atom Chemical group O* 0.000 description 3
- 229920000036 polyvinylpyrrolidone Polymers 0.000 description 3
- 239000001267 polyvinylpyrrolidone Substances 0.000 description 3
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 description 3
- 239000011148 porous material Substances 0.000 description 3
- 239000000047 product Substances 0.000 description 3
- 239000011780 sodium chloride Substances 0.000 description 3
- 210000004989 spleen cell Anatomy 0.000 description 3
- LENZDBCJOHFCAS-UHFFFAOYSA-N tris Chemical compound OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 description 3
- HDTRYLNUVZCQOY-UHFFFAOYSA-N α-D-glucopyranosyl-α-D-glucopyranoside Natural products OC1C(O)C(O)C(CO)OC1OC1C(O)C(O)C(O)C(CO)O1 HDTRYLNUVZCQOY-UHFFFAOYSA-N 0.000 description 2
- JKMHFZQWWAIEOD-UHFFFAOYSA-N 2-[4-(2-hydroxyethyl)piperazin-1-yl]ethanesulfonic acid Chemical compound OCC[NH+]1CCN(CCS([O-])(=O)=O)CC1 JKMHFZQWWAIEOD-UHFFFAOYSA-N 0.000 description 2
- 238000011725 BALB/c mouse Methods 0.000 description 2
- 206010006448 Bronchiolitis Diseases 0.000 description 2
- 238000009007 Diagnostic Kit Methods 0.000 description 2
- BWGNESOTFCXPMA-UHFFFAOYSA-N Dihydrogen disulfide Chemical compound SS BWGNESOTFCXPMA-UHFFFAOYSA-N 0.000 description 2
- 238000002965 ELISA Methods 0.000 description 2
- 108091006027 G proteins Proteins 0.000 description 2
- 102000030782 GTP binding Human genes 0.000 description 2
- 108091000058 GTP-Binding Proteins 0.000 description 2
- 102000003886 Glycoproteins Human genes 0.000 description 2
- 108090000288 Glycoproteins Proteins 0.000 description 2
- 239000007995 HEPES buffer Substances 0.000 description 2
- 241000699666 Mus <mouse, genus> Species 0.000 description 2
- 241000699670 Mus sp. Species 0.000 description 2
- WHNWPMSKXPGLAX-UHFFFAOYSA-N N-Vinyl-2-pyrrolidone Chemical compound C=CN1CCCC1=O WHNWPMSKXPGLAX-UHFFFAOYSA-N 0.000 description 2
- 239000000020 Nitrocellulose Substances 0.000 description 2
- 102000007999 Nuclear Proteins Human genes 0.000 description 2
- 108010089610 Nuclear Proteins Proteins 0.000 description 2
- 239000004677 Nylon Substances 0.000 description 2
- 206010035226 Plasma cell myeloma Diseases 0.000 description 2
- 206010035664 Pneumonia Diseases 0.000 description 2
- WCUXLLCKKVVCTQ-UHFFFAOYSA-M Potassium chloride Chemical compound [Cl-].[K+] WCUXLLCKKVVCTQ-UHFFFAOYSA-M 0.000 description 2
- 102000004389 Ribonucleoproteins Human genes 0.000 description 2
- 108010081734 Ribonucleoproteins Proteins 0.000 description 2
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 2
- 229930006000 Sucrose Natural products 0.000 description 2
- HDTRYLNUVZCQOY-WSWWMNSNSA-N Trehalose Natural products O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-WSWWMNSNSA-N 0.000 description 2
- HDTRYLNUVZCQOY-LIZSDCNHSA-N alpha,alpha-trehalose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-LIZSDCNHSA-N 0.000 description 2
- 239000007864 aqueous solution Substances 0.000 description 2
- 230000005540 biological transmission Effects 0.000 description 2
- 239000002981 blocking agent Substances 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 230000004927 fusion Effects 0.000 description 2
- 230000003100 immobilizing effect Effects 0.000 description 2
- 229910017053 inorganic salt Inorganic materials 0.000 description 2
- 239000011259 mixed solution Substances 0.000 description 2
- 239000000178 monomer Substances 0.000 description 2
- 201000000050 myeloid neoplasm Diseases 0.000 description 2
- 229920001220 nitrocellulos Polymers 0.000 description 2
- 229910052757 nitrogen Inorganic materials 0.000 description 2
- 125000004433 nitrogen atom Chemical group N* 0.000 description 2
- 229920001778 nylon Polymers 0.000 description 2
- 210000003200 peritoneal cavity Anatomy 0.000 description 2
- 239000012071 phase Substances 0.000 description 2
- 239000008055 phosphate buffer solution Substances 0.000 description 2
- 229920003023 plastic Polymers 0.000 description 2
- 239000004033 plastic Substances 0.000 description 2
- 229920000642 polymer Polymers 0.000 description 2
- XOJVVFBFDXDTEG-UHFFFAOYSA-N pristane Chemical compound CC(C)CCCC(C)CCCC(C)CCCC(C)C XOJVVFBFDXDTEG-UHFFFAOYSA-N 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 230000000241 respiratory effect Effects 0.000 description 2
- 239000012898 sample dilution Substances 0.000 description 2
- 230000028327 secretion Effects 0.000 description 2
- 239000007787 solid Substances 0.000 description 2
- 229960004793 sucrose Drugs 0.000 description 2
- GPRLSGONYQIRFK-MNYXATJNSA-N triton Chemical compound [3H+] GPRLSGONYQIRFK-MNYXATJNSA-N 0.000 description 2
- OWEGMIWEEQEYGQ-UHFFFAOYSA-N 100676-05-9 Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC2C(OC(O)C(O)C2O)CO)O1 OWEGMIWEEQEYGQ-UHFFFAOYSA-N 0.000 description 1
- CWWYEELVMRNKHZ-UHFFFAOYSA-N 2,3-dimethylbut-2-enamide Chemical compound CC(C)=C(C)C(N)=O CWWYEELVMRNKHZ-UHFFFAOYSA-N 0.000 description 1
- HRPVXLWXLXDGHG-UHFFFAOYSA-N Acrylamide Chemical compound NC(=O)C=C HRPVXLWXLXDGHG-UHFFFAOYSA-N 0.000 description 1
- 102000002260 Alkaline Phosphatase Human genes 0.000 description 1
- 108020004774 Alkaline Phosphatase Proteins 0.000 description 1
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 description 1
- BTBUEUYNUDRHOZ-UHFFFAOYSA-N Borate Chemical compound [O-]B([O-])[O-] BTBUEUYNUDRHOZ-UHFFFAOYSA-N 0.000 description 1
- 241000283690 Bos taurus Species 0.000 description 1
- 241000283707 Capra Species 0.000 description 1
- 241000700199 Cavia porcellus Species 0.000 description 1
- KRKNYBCHXYNGOX-UHFFFAOYSA-K Citrate Chemical compound [O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O KRKNYBCHXYNGOX-UHFFFAOYSA-K 0.000 description 1
- 229920000742 Cotton Polymers 0.000 description 1
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 1
- 241000283073 Equus caballus Species 0.000 description 1
- 108010010803 Gelatin Proteins 0.000 description 1
- 239000004366 Glucose oxidase Substances 0.000 description 1
- 108010015776 Glucose oxidase Proteins 0.000 description 1
- 108010001336 Horseradish Peroxidase Proteins 0.000 description 1
- 108060003951 Immunoglobulin Proteins 0.000 description 1
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 1
- 206010067508 Low birth weight baby Diseases 0.000 description 1
- GUBGYTABKSRVRQ-PICCSMPSSA-N Maltose Natural products O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-PICCSMPSSA-N 0.000 description 1
- 229930195725 Mannitol Natural products 0.000 description 1
- 108091028043 Nucleic acid sequence Proteins 0.000 description 1
- 229910019142 PO4 Inorganic materials 0.000 description 1
- 241000711504 Paramyxoviridae Species 0.000 description 1
- 241001494479 Pecora Species 0.000 description 1
- 102000007079 Peptide Fragments Human genes 0.000 description 1
- 108010033276 Peptide Fragments Proteins 0.000 description 1
- 241000009328 Perro Species 0.000 description 1
- 241000276498 Pollachius virens Species 0.000 description 1
- 239000004695 Polyether sulfone Substances 0.000 description 1
- 229920001213 Polysorbate 20 Polymers 0.000 description 1
- 229920001214 Polysorbate 60 Polymers 0.000 description 1
- 239000004372 Polyvinyl alcohol Substances 0.000 description 1
- 241000700159 Rattus Species 0.000 description 1
- 229920000297 Rayon Polymers 0.000 description 1
- 208000035415 Reinfection Diseases 0.000 description 1
- 206010057190 Respiratory tract infections Diseases 0.000 description 1
- 241000282898 Sus scrofa Species 0.000 description 1
- 108010046334 Urease Proteins 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 238000001042 affinity chromatography Methods 0.000 description 1
- 238000001261 affinity purification Methods 0.000 description 1
- 125000005250 alkyl acrylate group Chemical group 0.000 description 1
- 150000005215 alkyl ethers Chemical class 0.000 description 1
- 125000000539 amino acid group Chemical group 0.000 description 1
- 239000002585 base Substances 0.000 description 1
- 102000005936 beta-Galactosidase Human genes 0.000 description 1
- 108010005774 beta-Galactosidase Proteins 0.000 description 1
- GUBGYTABKSRVRQ-QUYVBRFLSA-N beta-maltose Chemical compound OC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O)[C@H](O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@@H]1O GUBGYTABKSRVRQ-QUYVBRFLSA-N 0.000 description 1
- 239000012472 biological sample Substances 0.000 description 1
- 239000007853 buffer solution Substances 0.000 description 1
- 230000002802 cardiorespiratory effect Effects 0.000 description 1
- 239000005018 casein Substances 0.000 description 1
- BECPQYXYKAMYBN-UHFFFAOYSA-N casein, tech. Chemical compound NCCCCC(C(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(CC(C)C)N=C(O)C(CCC(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(C(C)O)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(COP(O)(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(N)CC1=CC=CC=C1 BECPQYXYKAMYBN-UHFFFAOYSA-N 0.000 description 1
- 235000021240 caseins Nutrition 0.000 description 1
- 238000004113 cell culture Methods 0.000 description 1
- 230000007910 cell fusion Effects 0.000 description 1
- 229920002301 cellulose acetate Polymers 0.000 description 1
- 238000010367 cloning Methods 0.000 description 1
- 238000004440 column chromatography Methods 0.000 description 1
- 238000011109 contamination Methods 0.000 description 1
- 238000012258 culturing Methods 0.000 description 1
- 210000000805 cytoplasm Anatomy 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- 235000014113 dietary fatty acids Nutrition 0.000 description 1
- 235000013681 dietary sucrose Nutrition 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 241001493065 dsRNA viruses Species 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 150000002170 ethers Chemical class 0.000 description 1
- 239000000194 fatty acid Substances 0.000 description 1
- 229930195729 fatty acid Natural products 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 239000012634 fragment Substances 0.000 description 1
- 108020001507 fusion proteins Proteins 0.000 description 1
- 102000037865 fusion proteins Human genes 0.000 description 1
- 229920000159 gelatin Polymers 0.000 description 1
- 239000008273 gelatin Substances 0.000 description 1
- 235000019322 gelatine Nutrition 0.000 description 1
- 235000011852 gelatine desserts Nutrition 0.000 description 1
- 229940116332 glucose oxidase Drugs 0.000 description 1
- 235000019420 glucose oxidase Nutrition 0.000 description 1
- ZBKIUFWVEIBQRT-UHFFFAOYSA-N gold(1+) Chemical compound [Au+] ZBKIUFWVEIBQRT-UHFFFAOYSA-N 0.000 description 1
- 239000001963 growth medium Substances 0.000 description 1
- 238000003306 harvesting Methods 0.000 description 1
- 208000019622 heart disease Diseases 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 238000003018 immunoassay Methods 0.000 description 1
- 102000018358 immunoglobulin Human genes 0.000 description 1
- 230000001771 impaired effect Effects 0.000 description 1
- 206010022000 influenza Diseases 0.000 description 1
- 230000002452 interceptive effect Effects 0.000 description 1
- 229920000831 ionic polymer Polymers 0.000 description 1
- 239000008101 lactose Substances 0.000 description 1
- 229960001375 lactose Drugs 0.000 description 1
- 239000004816 latex Substances 0.000 description 1
- 229920000126 latex Polymers 0.000 description 1
- 208000030500 lower respiratory tract disease Diseases 0.000 description 1
- 229960002160 maltose Drugs 0.000 description 1
- 239000000594 mannitol Substances 0.000 description 1
- 235000010355 mannitol Nutrition 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 239000002609 medium Substances 0.000 description 1
- 229910044991 metal oxide Inorganic materials 0.000 description 1
- 150000004706 metal oxides Chemical class 0.000 description 1
- FQPSGWSUVKBHSU-UHFFFAOYSA-N methacrylamide Chemical compound CC(=C)C(N)=O FQPSGWSUVKBHSU-UHFFFAOYSA-N 0.000 description 1
- 239000013642 negative control Substances 0.000 description 1
- 229910052755 nonmetal Inorganic materials 0.000 description 1
- 239000004745 nonwoven fabric Substances 0.000 description 1
- 244000052769 pathogen Species 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 1
- 239000010452 phosphate Substances 0.000 description 1
- 229920000728 polyester Polymers 0.000 description 1
- 229920006393 polyether sulfone Polymers 0.000 description 1
- 229920000098 polyolefin Polymers 0.000 description 1
- 239000000256 polyoxyethylene sorbitan monolaurate Substances 0.000 description 1
- 235000010486 polyoxyethylene sorbitan monolaurate Nutrition 0.000 description 1
- 229920000136 polysorbate Polymers 0.000 description 1
- 229920002451 polyvinyl alcohol Polymers 0.000 description 1
- 239000013641 positive control Substances 0.000 description 1
- 239000001103 potassium chloride Substances 0.000 description 1
- 235000011164 potassium chloride Nutrition 0.000 description 1
- 239000002243 precursor Substances 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 238000003908 quality control method Methods 0.000 description 1
- 239000002964 rayon Substances 0.000 description 1
- 208000020029 respiratory tract infectious disease Diseases 0.000 description 1
- 238000012216 screening Methods 0.000 description 1
- 238000011896 sensitive detection Methods 0.000 description 1
- 235000020183 skimmed milk Nutrition 0.000 description 1
- 239000007790 solid phase Substances 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 210000000952 spleen Anatomy 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 235000000346 sugar Nutrition 0.000 description 1
- 150000005846 sugar alcohols Chemical class 0.000 description 1
- 239000006228 supernatant Substances 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 229920001059 synthetic polymer Polymers 0.000 description 1
- 229940074410 trehalose Drugs 0.000 description 1
- 210000004881 tumor cell Anatomy 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
- G01N33/56983—Viruses
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01D—SEPARATION
- B01D15/00—Separating processes involving the treatment of liquids with solid sorbents; Apparatus therefor
- B01D15/08—Selective adsorption, e.g. chromatography
- B01D15/26—Selective adsorption, e.g. chromatography characterised by the separation mechanism
- B01D15/265—Adsorption chromatography
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01D—SEPARATION
- B01D15/00—Separating processes involving the treatment of liquids with solid sorbents; Apparatus therefor
- B01D15/08—Selective adsorption, e.g. chromatography
- B01D15/26—Selective adsorption, e.g. chromatography characterised by the separation mechanism
- B01D15/38—Selective adsorption, e.g. chromatography characterised by the separation mechanism involving specific interaction not covered by one or more of groups B01D15/265 - B01D15/36
- B01D15/3804—Affinity chromatography
- B01D15/3819—Affinity chromatography of the nucleic acid-nucleic acid binding protein type
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/08—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses
- C07K16/10—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses from RNA viruses
- C07K16/1027—Paramyxoviridae, e.g. respiratory syncytial virus
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/005—Assays involving biological materials from specific organisms or of a specific nature from viruses
- G01N2333/08—RNA viruses
- G01N2333/115—Paramyxoviridae, e.g. parainfluenza virus
- G01N2333/135—Respiratory syncytial virus
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Immunology (AREA)
- Molecular Biology (AREA)
- Virology (AREA)
- Analytical Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- Biomedical Technology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Urology & Nephrology (AREA)
- Hematology (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Organic Chemistry (AREA)
- Tropical Medicine & Parasitology (AREA)
- Pathology (AREA)
- Food Science & Technology (AREA)
- Biotechnology (AREA)
- Cell Biology (AREA)
- Physics & Mathematics (AREA)
- Microbiology (AREA)
- General Physics & Mathematics (AREA)
- Pulmonology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Peptides Or Proteins (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Claims (11)
1. Immunkromatografianordning, der omfatter et kromatografimedium med et bestemmelsesområde, hvorpå mindst ét antistof, der specifikt binder til et F-protein af respiratorisk syncytialvirus (RSV), og mindst ét antistof, der specifikt binder til et N-protein af RSV, er immobiliseret.
2. Immunkromatografianordningen ifølge krav 1, der i alt væsentligt omfatter en prøvetilsætningsdel, kromatografi med i et og en absorptionsdel.
3. Immunkromatografianordningen ifølge krav 2, der endvidere omfatter en mærkningsreagensholdig del.
4. Immunkromatografianordningen ifølge krav 1 til 3, hvor antistoffet, der specifikt binder til F-proteinet, er mindst ét antistof, der specifikt binder til ét af eller både et F-protein af undergruppe A af RSV og et F-protein af undergruppe B af RSV.
5. Immunkromatografisk testkit til RSV, der omfatter: en immunkromatografianordning ifølge krav 1, der omfatter et kromatografimedium med et bestemmelsesområde, hvorpå mindst ét antistof, der specifikt binder til et F-protein af RSV, og mindst ét antistof, der specifikt binder til et N-protein af RSV, er immobiliseret; og en prøvefortynder.
6. Immunkromatografisk testkit til RSV ifølge krav 5, hvor immunkromatografianordningen i alt væsentligt indbefatter en prøvetilsætningsdel, kromatografimediet og en absorptionsdel.
7. Immunkromatografisk testkit til RSV ifølge krav 6, hvor immunkromatografianordningen endvidere indbefatter en mærkningsreagensholdig del.
8. Immunkromatografisk testkit til RSV ifølge krav 6, der endvidere omfatter en mærkningsreagensopløsning.
9. Anvendelse af en immunkromatografianordning med et bestemmelsesområde, hvorpå mindst ét antistof, der specifikt binder til et F-protein af respiratorisk syncytialvirus (RSV), og mindst ét antistof, der specifikt binder til et N-protein af RSV, er immobiliseret for at detektere RSV.
10. Immunkromatografisk fremgangsmåde til detektering af respiratorisk syncytialvirus (RSV), der omfatter: (a) tilførsel af en prøvevæske, der indeholder en prøve, til en immunkromatografianordning, hvori mindst ét antistof, der specifikt binder til et F-protein af RSV, og mindst ét antistof, der specifikt binder til et N-protein af RSV, er immobiliseret på et bestemmelsesområde; (b) at lade prøvevæsken tilført i trin (a) passere gennem bestemmelsesområdet sammen med et mærkningsreagens; (c) at bringe prøvevæsken, der indeholder mærkningsreagenset, i kontakt med de immobiliserede antistoffer i bestemmelsesområdet; og (d) bestemmelse af prøven som "RSV-positiv", når farvning forårsaget af mærkningsreagenset detekteres.
11. Immunkromatografisk fremgangsmåde til detektering af RSV ifølge krav 10, der endvidere omfatter et trin med fortynding af prøven med en prøvefortynder, før prøven tilføres immunkromatografianordningen.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2013130095 | 2013-06-21 | ||
| PCT/JP2014/066378 WO2014203988A1 (ja) | 2013-06-21 | 2014-06-20 | Ｒｓｖを検出するためのイムノクロマトグラフィー装置 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK3012633T3 true DK3012633T3 (da) | 2018-08-13 |
Family
ID=52104714
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK14814429.8T DK3012633T3 (da) | 2013-06-21 | 2014-06-20 | Immunkromatografianordning til detektering af RSV |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US10234456B2 (da) |
| EP (1) | EP3012633B1 (da) |
| JP (1) | JP6454274B2 (da) |
| CN (1) | CN105324669B (da) |
| DK (1) | DK3012633T3 (da) |
| ES (1) | ES2683169T3 (da) |
| WO (1) | WO2014203988A1 (da) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN105606798A (zh) * | 2016-04-08 | 2016-05-25 | 四川新健康成生物股份有限公司 | 一种免疫荧光层析检测用样本稀释液 |
| JP2020122773A (ja) * | 2019-01-31 | 2020-08-13 | 田中貴金属工業株式会社 | デングウイルス検出用免疫クロマト分析装置 |
| JP7267548B2 (ja) * | 2019-04-24 | 2023-05-02 | 株式会社ニップン | トマト黄化葉巻ウイルス（ｔｙｌｃｖ）の免疫学的診断法 |
| JP2021073934A (ja) * | 2019-11-12 | 2021-05-20 | デンカ株式会社 | 抗ｒｓウイルスｎ蛋白質を認識する抗体、並びに該抗体を用いた免疫測定方法及び免疫測定器具 |
| JP7479135B2 (ja) | 2019-11-12 | 2024-05-08 | デンカ株式会社 | 抗ｒｓウイルスを認識する抗体、並びに該抗体を用いた免疫測定方法及び免疫測定器具 |
| JP2021092517A (ja) * | 2019-12-12 | 2021-06-17 | デンカ株式会社 | 免疫測定方法及び免疫測定器具 |
| US20210199652A1 (en) * | 2019-12-31 | 2021-07-01 | Panion & Bf Biotech Inc. | Test Kit For Detecting A Plurality Of Analytes |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5811524A (en) | 1995-06-07 | 1998-09-22 | Idec Pharmaceuticals Corporation | Neutralizing high affinity human monoclonal antibodies specific to RSV F-protein and methods for their manufacture and therapeutic use thereof |
| AU1038402A (en) * | 2000-10-17 | 2002-04-29 | Besst Test Aps | Assay for directly detecting a rs virus related biological cell in a body fluid sample |
| CA2430039C (en) | 2000-11-28 | 2014-01-28 | Medimmune, Inc. | Methods of administering/dosing anti-rsv antibodies for prophylaxis and treatment |
| ITRM20030386A1 (it) | 2003-08-05 | 2005-02-06 | Istituto Naz Per Le Malattie Infettive Lazz | Metodo e test diagnostici basati sull'analisi citofluorimetrica dei linfociti t antigene-specifici. |
| JP2008014751A (ja) | 2006-07-05 | 2008-01-24 | Denka Seiken Co Ltd | 着色ラテックス粒子を用いるメンブレンアッセイ法およびキット |
| JP4339906B2 (ja) | 2006-10-19 | 2009-10-07 | デンカ生研株式会社 | 試料ろ過フィルターを用いる簡易メンブレンアッセイ方法及びキット |
| JP5431644B2 (ja) | 2006-12-28 | 2014-03-05 | シスメックス株式会社 | 呼吸器感染症の検査方法 |
| JP5575377B2 (ja) | 2008-07-18 | 2014-08-20 | シスメックス株式会社 | 抗ｒｓウイルスモノクローナル抗体を用いたｒｓウイルス検出用キット及びイムノクロマトグラフィー用試験具、並びに新規な抗ｒｓウイルスモノクローナル抗体 |
| KR101778317B1 (ko) * | 2009-08-13 | 2017-09-13 | 얀센 백신스 앤드 프리벤션 비.브이. | 사람 호흡기 세포융합 바이러스(ｒｓｖ)에 대한 항체 및 이용 방법 |
| EP2606353A4 (en) * | 2010-08-18 | 2014-10-15 | Caris Life Sciences Luxembourg Holdings | CIRCULATING BIOMARKERS FOR DISEASE |
| JP2012083370A (ja) | 2012-01-31 | 2012-04-26 | Denka Seiken Co Ltd | 着色ラテックス粒子を用いるメンブレンアッセイ法およびキット |
-
2014
- 2014-06-20 WO PCT/JP2014/066378 patent/WO2014203988A1/ja active Application Filing
- 2014-06-20 DK DK14814429.8T patent/DK3012633T3/da active
- 2014-06-20 US US14/899,248 patent/US10234456B2/en active Active
- 2014-06-20 ES ES14814429.8T patent/ES2683169T3/es active Active
- 2014-06-20 JP JP2015522987A patent/JP6454274B2/ja active Active
- 2014-06-20 EP EP14814429.8A patent/EP3012633B1/en active Active
- 2014-06-20 CN CN201480035447.0A patent/CN105324669B/zh active Active
Also Published As
| Publication number | Publication date |
|---|---|
| US20160139125A1 (en) | 2016-05-19 |
| ES2683169T3 (es) | 2018-09-25 |
| EP3012633A1 (en) | 2016-04-27 |
| JP6454274B2 (ja) | 2019-01-16 |
| JPWO2014203988A1 (ja) | 2017-02-23 |
| CN105324669A (zh) | 2016-02-10 |
| EP3012633A4 (en) | 2017-01-18 |
| EP3012633B1 (en) | 2018-07-18 |
| US10234456B2 (en) | 2019-03-19 |
| CN105324669B (zh) | 2017-09-15 |
| WO2014203988A1 (ja) | 2014-12-24 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK3012633T3 (da) | Immunkromatografianordning til detektering af RSV | |
| JP7260192B2 (ja) | マイコプラズマ・ニューモニエの免疫学的検出法およびキット | |
| EP2833147B1 (en) | Detection kit for influenza a virus | |
| JP5575377B2 (ja) | 抗ｒｓウイルスモノクローナル抗体を用いたｒｓウイルス検出用キット及びイムノクロマトグラフィー用試験具、並びに新規な抗ｒｓウイルスモノクローナル抗体 | |
| KR20190029573A (ko) | 면역 크로마토그래피를 이용한 검출 방법 | |
| JP2024012473A (ja) | Ｒｓウイルスを検出するための検出用試薬又はキット及びｒｓウイルスを検出する方法 | |
| JP6906207B2 (ja) | チクングニアウイルス検出用免疫クロマト分析装置 | |
| EP2856163B1 (en) | Method for diagnosing and differentiating hiv-2 infections | |
| WO2023277143A1 (ja) | ＳＡＲＳ－ＣｏＶ－２のヌクレオカプシドタンパク質に対する抗体及びその用途 | |
| WO2021117862A1 (ja) | 免疫測定方法及び免疫測定器具 | |
| EP4059958A1 (en) | Anti?rs virus n protein?recognizing antibody, immunoassay method and immunoassay instrument using anti?rs virus n protein?recognizing antibody | |
| US20220050102A1 (en) | Lateral Flow Device for Detecting SARS-CoV-2 Antibodies in Human and Animal Samples | |
| RU2808765C2 (ru) | Набор для выявления антител классов M и G к нуклеокапсиду (Nc) и рецепторсвязывающему домену спайк белка коронавируса SARS-CoV-2 | |
| JP2024005344A (ja) | 検査方法、イムノクロマトグラフィーテストストリップ、及びイムノクロマトグラフィーキット | |
| EP4241085A1 (en) | Lateral flow devices for high sensitivity detection of coronavirus infection, and methods of making and using the same |